ストックスクリーナーアプリを入手
22.63
0.79%
-0.18
アフターアワーズ：
22.63
前日終値:
$22.81
開ける：
$22.97
24時間の取引高:
259.24K
Relative Volume:
0.78
時価総額：
$1.21B
収益：
-
当期純損益:
$-83.74M
株価収益率:
-14.06
EPS:
-1.61
ネットキャッシュフロー:
$-64.98M
1週間 パフォーマンス:
+5.26%
1か月 パフォーマンス:
+46.19%
6か月 パフォーマンス:
+119.07%
1年 パフォーマンス:
+49.18%
1日の値動き範囲:
$22.06
$23.39
1週間の範囲:
$21.66
$24.05
52週間の値動き範囲:
$6.42
$24.05
Tyra Biosciences Inc Stock (TYRA) Company Profile
TYRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
22.63 | 1.22B | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 開始されました | Raymond James | Strong Buy |
| 2025-05-21 | 再開されました | Piper Sandler | Overweight |
| 2025-01-07 | 開始されました | UBS | Buy |
| 2024-10-18 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-08-15 | 開始されました | Piper Sandler | Overweight |
| 2023-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-06-30 | 開始されました | Wedbush | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-06-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-03-08 | アップグレード | Jefferies | Hold → Buy |
| 2021-11-08 | ダウングレード | Jefferies | Buy → Hold |
| 2021-10-11 | 開始されました | BofA Securities | Buy |
| 2021-10-11 | 開始されました | Cowen | Outperform |
| 2021-10-11 | 開始されました | Jefferies | Buy |
すべてを表示
Tyra Biosciences Inc (TYRA) 最新ニュース
June Brings on Some Huge Insider Buying - AOL.com
Understanding the Setup: (TYRA) and Scalable Risk - news.stocktradersdaily.com
How Investors Are Reacting To Tyra Biosciences (TYRA) Bolstering Its Regulatory And Oncology Leadership - Sahm
Tyra Biosciences stock hits 52-week high at 22.83 USD By Investing.com - Investing.com Canada
Tyra Biosciences stock hits 52-week high at 22.83 USD - Investing.com
Tyra Biosciences (NASDAQ:TYRA) Raised to “Hold” at Wall Street Zen - Defense World
Tyra Biosciences (NASDAQ:TYRA) Raised to "Hold" at Wall Street Zen - MarketBeat
What makes Tyra Biosciences Inc. stock attractive to growth funds2025 Pullback Review & Stock Portfolio Risk Management - Newser
Aug Mood: Why Tyra Biosciences Inc. stock attracts high net worth investorsJuly 2025 Chart Watch & High Win Rate Trade Tips - moha.gov.vn
Can Tyra Biosciences Inc. stock resist market sell offsJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
Goldman Sachs initiates coverage of Tyra Biosciences stock with Early-Stage Biotech rating - Investing.com UK
Tyra Biosciences (TYRA): Assessing Valuation After New Leadership Hires to Drive Dabogratinib Pipeline Forward - Sahm
Sio Capital Management LLC Has $7.75 Million Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences (TYRA) Stock Analysis Report | Financials & Insights - Benzinga
Should Tyra Biosciences’ (TYRA) Executive Hires Shift the Regulatory Outlook for Its Pipeline? - Sahm
Tyra Biosciences (NASDAQ:TYRA) Shares Gap DownHere's What Happened - MarketBeat
Tyra Biosciences appoints two key executives to leadership team By Investing.com - Investing.com Canada
Novo Nordisk’s Miriam Frieden to lead BD at Lundbeck - biocentury.com
Tyra Biosciences appoints two key executives to leadership team - Investing.com
Tyra Biosciences Announces Executive Role Changes - TradingView
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer - Eastern Progress
Contrasting Milestone Pharmaceuticals (NASDAQ:MIST) and Tyra Biosciences (NASDAQ:TYRA) - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bull Bear: How Tyra Biosciences Inc. stock reacts to global recession fearsMarket Weekly Review & Weekly Chart Analysis and Guides - moha.gov.vn
Weekly Recap: Why Tyra Biosciences Inc. stock attracts high net worth investorsLong Setup & Fast Exit and Entry Strategy Plans - moha.gov.vn
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighWhat's Next? - MarketBeat
Dynamic Technology Lab Private Ltd Takes $326,000 Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Director Robert More Sells 246,871 Shares - MarketBeat
Tyra Biosciences (TYRA): Evaluating Valuation Following Phase 2 Milestone in Achondroplasia Pipeline - simplywall.st
Dir More Sells 246,871 ($5M) Of Tyra Biosciences Inc [TYRA] - TradingView
Check Out Tyra Biosciences Inc (TYRA)’s Trade Data Rather Than the Analysts’ Views - Setenews
Immunic Inc (IMUX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Non Muscle Invasive Bladder Cancer Pipeline Insights Report 2025: Emerging Therapies and Key Clinical Advances Reshaping the Future of Treatment - Barchart.com
Best Growth Stocks To Follow Today – November 22nd - Defense World
Insiders Who Sold US$628k Of Tyra Biosciences Made The Right Call - simplywall.st
Why Tyra Biosciences (TYRA) Is Up 34.3% After Launching Phase 2 Trial in Pediatric Achondroplasia - Sahm
Tyra Biosciences stock hits 52-week high at 21.19 USD By Investing.com - Investing.com Nigeria
What Makes Shree Ganesh Bio a Strong Contender in YEARHigh Frequency Trading Trends & Free Exceptional Risk Adjusted Gains - earlytimes.in
Tyra Biosciences stock hits 52-week high at 21.19 USD - Investing.com
There is no doubt that Tyra Biosciences Inc (TYRA) ticks all the boxes. - Setenews
Tyra Biosciences Insider Sold Shares Worth $2,030,923, According to a Recent SEC Filing - MarketScreener
Tyra Biosciences COO Bensen sells $2m in stock By Investing.com - Investing.com India
Is Tyra Biosciences Inc. stock supported by strong fundamentalsJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Insider Sell: Daniel Bensen Sells 125,589 Shares of Tyra Bioscie - GuruFocus
Risk vs reward if holding onto Tyra Biosciences Inc.Weekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Can technical indicators confirm Tyra Biosciences Inc.’s reversalQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com
Will Tyra Biosciences Inc. continue its uptrendEarnings Risk Report & Fast Gain Stock Tips - newser.com
Should I hold or sell Tyra Biosciences Inc. stock in 2025Trade Volume Summary & Daily Stock Trend Watchlist - newser.com
Is Tyra Biosciences Inc. forming a reversal patternMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Has Tyra Biosciences Inc. found a price floorJobs Report & Momentum Based Trading Signals - newser.com
Tyra Biosciences Inc (TYRA) 財務データ
収益
当期純利益
現金流量
EPS
Tyra Biosciences Inc (TYRA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MORE ROBERT J | Director |
Nov 21 '25 |
Sale |
20.25 |
246,871 |
5,000,026 |
3,833,425 |
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):